Drug-loaded nanoparticles zero in on tumors
Scientists at BIND Biosciences developed nanoparticles loaded with drugs that can effectively target tumors by staying in the bloodstream for more than a day. They hope the nanoparticles, which are coated with cancer-targeting proteins, can minimize side effects of chemotherapy.
MIT Technology Review | 11/04
This story published in BIO SmartBrief on 11/04/2009
More from SmartBrief:
Hepatitis C drug from Idenix well-tolerated in study
Wednesday, July 22, 2009
Sepracor's depression drug fails trial; Lunesta studies on hold
Thursday, July 2, 2009
FDA clears Arzerra for chronic lymphocytic leukemia
Tuesday, October 27, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|